Mayne Pharma Group (OTCMKTS:MAYNF) Shares Down 9.7% – Here’s What Happened

Mayne Pharma Group Limited (OTCMKTS:MAYNF)’s stock price fell 9.7% on Monday . The stock traded as low as $2.13 and last traded at $2.13. 150 shares changed hands during mid-day trading, a decline of 95% from the average session volume of 3,106 shares. The stock had previously closed at $2.36.

Mayne Pharma Group Price Performance

The business has a fifty day moving average of $2.87 and a 200 day moving average of $3.19.

About Mayne Pharma Group

Mayne Pharma Group (OTCMKTS:MAYNF) is a specialty pharmaceutical company focused on the development, manufacturing and commercialization of prescription products. The company’s portfolio spans oral, transdermal and topical dosage forms, with a particular emphasis on women’s health, dermatology, pain management and other niche therapeutic areas. Through both branded and generic offerings, Mayne Pharma seeks to address unmet patient needs and provide cost-effective alternatives to established treatments.

In its development operations, Mayne Pharma leverages a combination of in-house research and external partnerships to advance product candidates through regulatory review.